|
|
News Breaks | | | | January 18, 2013 | | 10:20 EDT |  | MON | EPA says Monsanto to transition away from single-trait rootworm corn In a memo dated January 17 in relation to the EPA's mitigation actions to address concerns related to rootworm resistance to certain strains of corn, the regulator stated it will be working with Monsanto (MON) to address these concerns. Monsanto has agreed to work with EPA to revise the regulatory definition "confirmed resistance" by March 2013. EPA said it understands that Monsanto intends to transition single mode of action products from the market over time. Monsanto agreed to annually report sales volumes to EPA and to "aggressively increase" the availability of pyramided products containing multiple corn rootworm toxins to replace single-trait Cry3Bb1. The EPA said in a separate document that its review concurred with the conclusions of published literature that documented instances of field failures in Iowa and Illinois due to resistance. Reference Link | |
|
News For MON From The Last 14 Days Check below for free stories on MON the last two weeks. |
|
|
| May 22, 2013 | | 14:56 EDT |  | MON | Insecticide sales robust as genetic modifications lose benefit, WSJ says Insecticide sales are ramping up strongly as American farmers plant more corn and a genetic modification designed to protect the crop from pests has begun to lose its effectiveness against pests, says the Wall Street Journal. Reference Link | | | May 20, 2013 | | 08:04 EDT |  | MON | BofA/Merrill's U.S. chemicals analyst holds an analyst/industry conference call
Subscribe for More Information | | | May 14, 2013 | | 17:48 EDT |  | MON | Lone Pine gives quarterly update on stakes NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES). | | | May 13, 2013 | | 16:25 EDT |  | MON | On The Fly: Closing Wrap Stocks on Wall Street were little changed from their opening levels as investors weighed the potential end of the Fed's quantitative easing program against a better than expected report on retail sales. The Wall Street Journal's Jon Hilsenrath suggested in a report over the weekend that the Federal Reserve has mapped a QE exit strategy. The report paired with the retail sales data left the market lacking conviction in either direction today, as the averages spent the majority of the session range-bound near the flatline. ECONOMIC EVENTS: In the U.S., retail sales rose 0.1% in April, which beat expectations for a 0.3% decline. Retail sales excluding autos, gas, and building materials rose 0.6%, which was also better than expected. Business inventories were flat in March, versus expectations for a 0.3% gain. In Asia, Chinese factory output grew 9.3% annually in April, which was up from 8.9% in March but still missed expectations for a 9.5% growth rate. COMPANY NEWS: The Supreme Court ruled unanimously that Monsanto's (MON) patented genetically altered soybeans are protected and that farmers cannot use them to create new seeds without paying the company... Dell's (DELL) special committee publicly asked for more information from Carl Icahn and Southeastern Asset Management about their proposed leveraged recapitalization. This request follows television interviews by Icahn last Friday in which he discussed his Dell proposal, as well as a weekend report in Barron's saying the Icahn and Southeastern plan could be a better deal for shareholders. MAJOR MOVERS: Among the notable gainers was Theravance (THRX), up $6.26, or 17.92%, to $41.20 after Elan Corporation (ELN) bought a stake in the potential future royalty payments from four respiratory programs partnered with GlaxoSmithKline (GSK) in exchange for $1B in cash. Also higher was Tesla (TSLA), which rose $11.04, or 14.38%, to $87.80 in its third straight double-digit percentage gain following a better-than-expected earnings report last week. Among the noteworthy losers was Barnes & Noble (BKS), down $2.21, or 9.48%, to $21.10 after the blog InsiderMonkey disputed a previous report about Microsoft's (MSFT) interest in the bookseller's NOOK assets. Also lower was JoS. A. Bank (JOSB), down $3.31, or 7.16%, to $42.90 after the company's first quarter earnings view came in below expectations. INDICES: The Dow was down 26.81, or 0.18%, to 15,091.68; the Nasdaq was up 2.21, or 0.06%, to 3,438.79; and the S&P 500 was nearly unchanged at 1,633.77. | | | 12:20 EDT |  | MON | On The Fly: Midday Wrap
Subscribe for More Information | | | 10:28 EDT |  | MON | Supreme Court upholds Monsanto win over seed patents
Subscribe for More Information | | | 10:06 EDT |  | MON | Supreme Court upholds patent win for Monsanto, Bloomberg reports
Subscribe for More Information | |
|
|
|
|
|
|